Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Larvin

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Biochemical Pharmacology|July 21, 2019
Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB<sub>1</sub>, TRPV1, and PPARαM A Karwad, D G Couch, K L Wright, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 11, 1999
Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortalityB J Ammori, P C Leeder, R F King, et al.
The British Journal of Surgery|January 30, 2003
Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admissionB J Ammori, K L Becker, P Kite, et al.
American Journal of Surgery|July 6, 2000
Relaparoscopy for the detection and treatment of complications of laparoscopic cholecystectomyS P Dexter, G V Miller, D Davides, et al.
Surgical Endoscopy|March 6, 2003
Micropuncture cholecystectomy vs conventional laparoscopic cholecystectomy: a randomized controlled trialW G Ainslie, J A Catton, D Davides, et al.
Pancreas|September 26, 2003
Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitisB J Ammori, K L Becker, P Kite, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
Gut|December 15, 2000
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitisC D Johnson, A N Kingsnorth, C W Imrie, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Biochemical Pharmacology|July 21, 2019
Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB<sub>1</sub>, TRPV1, and PPARαM A Karwad, D G Couch, K L Wright, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 11, 1999
Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortalityB J Ammori, P C Leeder, R F King, et al.
The British Journal of Surgery|January 30, 2003
Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admissionB J Ammori, K L Becker, P Kite, et al.
American Journal of Surgery|July 6, 2000
Relaparoscopy for the detection and treatment of complications of laparoscopic cholecystectomyS P Dexter, G V Miller, D Davides, et al.
Surgical Endoscopy|March 6, 2003
Micropuncture cholecystectomy vs conventional laparoscopic cholecystectomy: a randomized controlled trialW G Ainslie, J A Catton, D Davides, et al.
Pancreas|September 26, 2003
Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitisB J Ammori, K L Becker, P Kite, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
Gut|December 15, 2000
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitisC D Johnson, A N Kingsnorth, C W Imrie, et al.
Pageof 5